Cross-national Analysis of Alcohol and Injury

酒精和伤害的跨国分析

基本信息

  • 批准号:
    9249434
  • 负责人:
  • 金额:
    $ 41.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This competing continuation builds on and extends research which analyzed ER data from the 12-site WHO Collaborative Study on Alcohol and Injuries, 33 sites in 8 countries comprising the Emergency Room Collaborative Alcohol Analysis Project (ERCAAP), and 30 sites in 13 countries added in the previous project period, data from studies all of which used similar methodology and instrumentation on probability samples of ER patients. Study aims are to: 1) examine risk of alcohol-related injury for self-reported consumption within 6 hours prior to all-cause injury and by injury cause (traffic, falls, intimate partner violence, other violence, burns, near drowning, poisoning, attempted suicide) by country/region level drinking patterns, context of drinking, alcohol control policy, and ER-level characteristics; 2) estimate relative risk (RR) of injury related to alcohol consumption volume (dose-response relationship) by cause of injury, comparing estimates with and without adjusting for individual-level injury context, and comparing estimates across regions of varying aggregate level detrimental drinking pattern (DDP), drinking context and alcohol policies; 3) estimate alcohol attributable fraction (AAF) by cause of injury, combining ER data and general population (GP) data, applying ER-based RR of injury related to drinking and predicted acute drinking exposure based on both individual-level and GP usual drinking pattern data. Aims address objectives of the Global Strategy to Reduce the Harmful Use of Alcohol, endorsed by the World Health Assembly in May 2010, in strengthening the knowledge base on the magnitude and determinants of alcohol-related harm, and, among other aims, will inform five of their 10 recommended policy target areas: community action, drinking-driving, alcohol availability, marketing of alcoholic beverages and pricing. Data will be added on 21,007 patients from 44 ER sites in 16 countries, cumulating in 43,453 injured patients from 119 ER sites covering 37 countries. Hierarchical linear modeling and case-crossover analysis and will examine contextual variables, including alcohol policy with individual and event-level variables on the alcohol-injury nexus, addressing a major gap in this literature. Coupled with GP data, this data set is one of a kind in providing the requisite number of patients to analyze specific alcohol policy control domains and variables in relation to specific causes of injury, adjust bias in RR of injury related to context of the event, and apply a new ER-based approach to estimating AAF by injury cause, based on both ER and GP drinking pattern data, which has the potential for extrapolation to countries with similar profiles (e.g., per capita consumption, DDP), for which ER studies are not available but GP pattern data are, and for GPs for which there are no exposure data, but where demographic and archival data are available. This work will, importantly, inform U.S. policy, potentially leading to policy change, as the U.S. is composed of many micro-cultures reflected in the contextual environment dominating many of the countries in which these data were collected.
描述(由申请人提供):这项竞争性延续研究建立在并扩展了研究,该研究分析了来自 12 个世卫组织酒精和伤害合作研究、8 个国家的 33 个地点(包括急诊室酒精合作分析项目 (ERCAAP))的 ER 数据,以及上一个项目期间添加的 13 个国家的 30 个地点的数据,所有研究的数据都使用类似的方法和仪器对 ER 患者的概率样本进行分析。研究目的是: 1) 按国家/地区水平的饮酒模式、饮酒背景、酒精控制政策和急诊室特征,检查全因伤害前 6 小时内自我报告的饮酒情况和伤害原因(交通、跌倒、亲密伴侣暴力、其他暴力、烧伤、溺水、中毒、自杀未遂)的酒精相关伤害风险; 2) 按伤害原因估计与饮酒量(剂量反应关系)相关的伤害相对风险(RR),比较调整和不调整个人伤害背景的估计值,并比较不同总体水平有害饮酒模式(DDP)、饮酒背景和酒精政策的地区的估计值; 3) 根据伤害原因估计酒精归因分数 (AAF),结合 ER 数据和一般人群 (GP) 数据,应用基于 ER 的饮酒相关伤害的 RR,并根据个人水平和 GP 惯常饮酒模式数据预测急性饮酒暴露。目标旨在实现2010年5月世界卫生大会批准的《减少有害使用酒精全球战略》的目标,加强关于酒精相关危害的程度和决定因素的知识库,除其他目标外,还将为他们建议的10个政策目标领域中的5个提供信息:社区行动、酒后驾驶、酒精供应、酒精饮料营销和定价。将添加来自 16 个国家 44 个急诊室的 21,007 名患者的数据,总计来自覆盖 37 个国家的 119 个急诊室的 43,453 名受伤患者。分层线性建模和案例交叉分析,并将检查背景变量,包括酒精政策以及酒精伤害的个人和事件层面变量 关系,解决了该文献中的一个主要空白。与全科医生数据相结合,该数据集是一种提供必要数量的患者来分析特定酒精政策控制领域和与特定伤害原因相关的变量,调整伤害相关的 RR 偏差的数据集之一。 根据事件的背景,应用一种新的基于 ER 的方法,根据 ER 和 GP 饮酒模式数据按伤害原因估计 AAF,该方法有可能外推到具有相似概况(例如人均消费量、DDP)的国家,这些国家没有 ER 研究,但有 GP 模式数据,以及没有暴露数据但有人口和档案数据的 GP。重要的是,这项工作将为美国政策提供信息,有可能导致政策变化,因为美国由许多微观文化组成,这些文化反映在主导许多收集这些数据的国家的背景环境中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHERYL J CHERPITEL其他文献

CHERYL J CHERPITEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHERYL J CHERPITEL', 18)}}的其他基金

COMPONENT 7: Methodologies for Improving Measurement of Alcohol Consumption and
组成部分 7:改进酒精消耗测量的方法和
  • 批准号:
    8597270
  • 财政年份:
    2014
  • 资助金额:
    $ 41.51万
  • 项目类别:
COMPONENT 7: Methodologies for Improving Measurement of Alcohol Consumption and
组成部分 7:改进酒精消耗量和酒精消耗测量的方法
  • 批准号:
    8403605
  • 财政年份:
    2013
  • 资助金额:
    $ 41.51万
  • 项目类别:
Screening and Brief Intervention in the ED among Mexican-origin Young Adults
墨西哥裔年轻人的急诊科筛查和短暂干预
  • 批准号:
    7783402
  • 财政年份:
    2010
  • 资助金额:
    $ 41.51万
  • 项目类别:
Screening and Brief Intervention in the ED among Mexican-origin Young Adults
墨西哥裔年轻人的急诊科筛查和短暂干预
  • 批准号:
    8074108
  • 财政年份:
    2010
  • 资助金额:
    $ 41.51万
  • 项目类别:
Screening and Brief Intervention in the ED among Mexican-origin Young Adults
墨西哥裔年轻人的急诊科筛查和短暂干预
  • 批准号:
    8270533
  • 财政年份:
    2010
  • 资助金额:
    $ 41.51万
  • 项目类别:
Brief Intervention in the ER in Poland
对波兰急诊室的简短干预
  • 批准号:
    7209884
  • 财政年份:
    2007
  • 资助金额:
    $ 41.51万
  • 项目类别:
Brief Intervention in the ER in Poland
对波兰急诊室的简短干预
  • 批准号:
    7371147
  • 财政年份:
    2007
  • 资助金额:
    $ 41.51万
  • 项目类别:
Alcohol and Injury: New Knowledge from ER Studies
酒精与伤害:急诊室研究的新知识
  • 批准号:
    6887971
  • 财政年份:
    2005
  • 资助金额:
    $ 41.51万
  • 项目类别:
Cross-National Analysis of Alcohol and Injury
酒精和伤害的跨国分析
  • 批准号:
    6532077
  • 财政年份:
    2002
  • 资助金额:
    $ 41.51万
  • 项目类别:
Cross-National Analysis of Alcohol & Injury
酒精的跨国分析
  • 批准号:
    7814440
  • 财政年份:
    2002
  • 资助金额:
    $ 41.51万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 41.51万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了